Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 5826 - 5850 of 6662 in total

5-(2-methylpiperazine-1-sulfonyl)isoquinoline

Experimental

Butedronic acid

Experimental

Fosmidomycin

Experimental
Investigational

Dipicolinic acid

Experimental

Tramiprosate

Investigational

Cloprostenol

Vet approved

BQ-123

BQ-123 has been investigated for the basic science and treatment of Coronary Artery Disease, Aorto-coronary Bypass Grafting, and ST-Elevation Myocardial Infarction.
Investigational

BR-007

Investigational

CRA_16847

Experimental

5-phospho-D-arabinohydroxamic acid

Experimental

CP-271485

Experimental

OptPA

Optimized tPA (OptPA; W253R/R275S-tPA) is an engineered variant of tPA designed to exhibit reduced neurotoxicity.
Investigational

2-deoxy-2-acetamido-beta-D-galactose-4-sulfate

Experimental

(2S)-2-(4-chlorophenoxy)-3-phenylpropanoic acid

Experimental

Ammonium bicarbonate

Experimental

Propofol Hemisuccinate

Experimental

AD-114

Investigational

Recifercept

Investigational

Rodatristat

Investigational

Cavrotolimod

Investigational

(2R,3R,4S,5R,6E)-3,4,5-Trihydroxy-N-[(3S,6R)-6-hydroxy-2-oxo-3-azepanyl]-2-methoxy-8,8-dimethyl-6-nonenamide

Experimental

N-{(3S)-1-[(Benzyloxy)sulfamoyl]-5-phenyl-3-pentanyl}-Nα-[(4-methyl-1-piperazinyl)carbonyl]-L-phenylalaninamide

Experimental

6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-(4-MORPHOLINYL)-2-OXO ETHYL]-2-OXO-3-PYRROLIDINYL}-2-NAPHTHALENESULFONAMIDE

Experimental

p-Toluenesulfonic acid

Experimental

Tuspetinib

Tuspetinib (HM-43239) is under investigation in clinical trial NCT03850574 (Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM43239 in Patients With Relapsed or Refractory Acute Myeloid Leukemia).
Investigational
Displaying drugs 5826 - 5850 of 6662 in total